← Back to grants
Grant✓ Small businesses may apply

GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

National Institutes of Health

Award ceiling

$2,250,000

Program funding

$3,000,000

Opportunity #
RFA-HG-27-012
Agency
National Institutes of Health
ALN (CFDA)
93.172
Status
posted
Posted
Jun 18, 2026
Closes
Oct 30, 2026
Funding instrument
Cooperative Agreement
Category
Health
Cost sharing required
No

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Synopsis

The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Funding Opportunity is to establish the GREGoRi Technology Integration Center, which will enable the development of standards and best practices for applying new and emerging molecular methods in rare disease diagnosis. A major deliverable of the Center will be a multidimensional dataset that can be used for the development and benchmarking of novel tools and strategies that facilitate rare disease diagnosis.

Contact

National Institutes of Health · nhgri-gregor@mail.nih.gov

View full notice on Grants.gov ↗